Moneycontrol

Budget 2023Budget 2023

PARTNERS

  • Tata AIA Life Insurance
  • Hafele
  • Motilal Oswal
  • SMC Global Securities Limited
  • SBI Life
  • DSP Mutual Fund
Upcoming Event : LeapToUnicorn - mentoring, networking and fundraising for startups. Register now
you are here: HomeNewsTrendsHealth

BioNTech eyes COVID-19 vaccine for 12-15 year olds from June in EU

The German firm's CEO Ugur Sahin told Der Spiegel weekly that it was "in the final stretches" of preparing its submission for European regulatory approval.

April 29, 2021 / 05:27 PM IST
(Image: Reuters)

(Image: Reuters)

BioNTech said Thursday that it expected its COVID-19 vaccine, jointly developed with Pfizer, to be available to 12 to 15-year-olds in Europe from June.

The German firm's CEO Ugur Sahin told Der Spiegel weekly that it was "in the final stretches" of preparing its submission for European regulatory approval.

The evaluation of the trial data "takes four to six weeks on average", he added.

Vaccinating children is seen as a crucial next step toward herd immunity and ending the pandemic.